Tag Archives: Alpharadin

Carbon Acetate PET Scans – Clinical Trials

Dr. Fabio Almeida introduces 3 clinical studies conducted by the Arizona Molecular Imaging Center.

Posted in Treatments for Prostate Cancer | Tagged , , | 1 Comment

Radium-223 ( Alpharadin): A novel Radiopharmaceutical that Prolongs Survival in Bone Metastatic Disease

  The following question is for the Ask Dr Barken Call In Show on Tuesday, March 13th at 6pm Pacific Time.  Dial 1-877-727-3301 to hear the program. Where can I get Alpharadin? What criteria will I need to meet to get … Continue reading

Posted in Ask Dr. Barken, Bone Metastases, Castration Resistant Prostate Cancer, Metastatic Disease, Metastatic Prostate Cancer Disease, Prostate Cancer, Radiation treatment, Survival prostate cancer, Treatments for Prostate Cancer | Tagged , | Leave a comment

Stromal Targeted Therapy in Bone Metastatic Disease

The following question is for the Ask Dr Barken Call In Show on Tuesday, March 6th at 6pm Pacific Time.  Dial 1-877-727-3301 to hear the program. Question of the week:    When should I start treating my bone metastatic disease?   … Continue reading

Posted in Bone Metastases, Castration Resistant Prostate Cancer, Hormone Refractory Disease, Metastatic Disease, Metastatic Prostate Cancer Disease, Treatments for Prostate Cancer | Tagged , , , | Leave a comment

Alpharadin- Experimental Treatment of Prostate Cancer Metastatic Disease in the Bones

Results of a Phase III trial with Alpharadin (radium 223-chloride) were presented at the European Cancer Organization and Congress of the European Society for Medical Oncology (ECCO-ESMO) conference in Stockholm this year.  Treatment with Alpharadin was associated with a 30% reduction … Continue reading

Posted in Metastatic Disease, Metastatic Prostate Cancer Disease, Radiation treatment, Treatments for Prostate Cancer | Tagged | 2 Comments